Effect of combined naltrexone and bupropion therapy on the brain's reactivity to food cues

OBJECTIVE: The significant weight loss observed with combination naltrexone-sustained release (SR) 32 mg and bupropion SR 360 mg (NB32) therapy is thought to be due, in part, to bupropion stimulation of hypothalamic pro-opiomelanocortin (POMC) neurons, and naltrexone blockade of opioid receptor-medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, G-J, Tomasi, D, Volkow, N D, Wang, R, Telang, F, Caparelli, E C, Dunayevich, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010969/
https://www.ncbi.nlm.nih.gov/pubmed/23924756
http://dx.doi.org/10.1038/ijo.2013.145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010969/
https://www.ncbi.nlm.nih.gov/pubmed/23924756
http://dx.doi.org/10.1038/ijo.2013.145

Ejemplares similares